Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imodium for Ileostomy Output Reduction
NCT02266849Phase 3Terminated
- Sponsor
- University Hospital Odense
- Start
- Oct 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of loperamide in rectal cancer, ulcerative colitis (UC), short bowel syndrome (SBS), sponsored by University Hospital Odense. Started Oct 2014; status: terminated.
02
Drugs
loperamide
03
Conditions
rectal cancerulcerative colitis (UC)short bowel syndrome (SBS)
Beyond the preview
Go deeper on NCT02266849.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02266849.